Law firm Halper Sadeh LLC is investigating the $23.50 per share cash acquisition of Surgery Partners, Inc. by HealthSpan Partners. The probe focuses on whether the board of directors breached fiduciary duties or violated federal securities laws by failing to secure the best possible price for shareholders and adequately disclosing material information regarding the transaction.
Halper Sadeh LLC is investigating whether the $23.50 per share cash sale of Surgery Partners to HealthSpan Partners breaches fiduciary duties. Such law-firm investigations are routine boilerplate after deal announcements and rarely change the share price; the stock should continue to trade near the $23.50 deal value, with only a small chance the probe wins extra consideration or extra disclosures.
- • Investigation into whether the $23.50 per share cash sale to HealthSpan Partners delivered the best possible price
- • Possible litigation seeking increased consideration or additional disclosures
- • The investigation is preliminary and expressly non-binding ('may seek' relief)
- • Insiders may receive substantial financial benefits not available to ordinary shareholders, and deal terms may limit superior competing offers